IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

  1. Lopez-Millan, B.
  2. Diaz de la Guardia, R.
  3. Roca-Ho, H.
  4. Anguita, E.
  5. Islam, A.B.M.M.K.
  6. Romero-Moya, D.
  7. Prieto, C.
  8. Gutierrez-Agüera, F.
  9. Bejarano-Garcia, J.A.
  10. Perez-Simon, J.A.
  11. Costales, P.
  12. Rovira, M.
  13. Marín, P.
  14. Menendez, S.
  15. Iglesias, M.
  16. Fuster, J.L.
  17. Urbano-Ispizua, A.
  18. Anjos-Afonso, F.
  19. Bueno, C.
  20. Menendez, P.
Journal:
OncoImmunology

ISSN: 2162-402X,  2162-4011

Year of publication: 2018

Volume: 7

Issue: 9

Type: Article

DOI: 10.1080/2162402X.2018.1477460 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus